Impact of MetS on Long-Term Prognosis Among STEMI Patients Treated with pPCI-Ten-Year Follow-Up Study.

Med Sci (Basel) · 2026 · PMC13214653 · PMID 42201060

Europe PMC DOI

hedged sentences

0.0630

closest p · 1.3× alpha

0.0860

boldest claim

The sentences

borderline significantp = 0.063so close (0.05 < p ≤ 0.1)

Statin use declined more sharply in the MetS-negative group (from 84.5% to 74.1%; McNemar p < 0.001) than in the MetS-positive group (from 88% to 72%); the between-group difference at month 60 was borderline significant ( p = 0.063). 3.3.

also in 11,409 other papers

did not reach statistical significancep = 0.086so close (0.05 < p ≤ 0.1)

For heart failure, the five-criteria subgroup showed a steep increase in incidence after month 72, reaching 38% at ten years; this did not reach statistical significance compared with the small reference group ( p = 0.086, with the three- and four-criteria subgroups both p > 0.4). 3.5.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.